Mirati Therapeutics
MRTX
#2994
Rank
A$6.57 B
Marketcap
$93.76
Share price
0.00%
Change (1 day)
61.81%
Change (1 year)

Earnings for Mirati Therapeutics (MRTX)

Earnings in 2023 (TTM): -A$1.16 Billion

According to Mirati Therapeutics's latest financial reports the company's current earnings are A$38.19 Million. In 2022 the company made an earning of -A$1.22 Billion a decrease over its 2021 earnings that were of -A$0.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mirati Therapeutics from 2008 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$1.16 Billion-5.2%
2022 -A$1.22 Billion32.52%
2021 -A$0.92 Billion55.18%
2020 -A$0.6 Billion66.3%
2019 -A$0.36 Billion116.42%
2018 -A$0.17 Billion43.47%
2017 -A$0.12 Billion-14.62%
2016 -A$0.14 Billion29.46%
2015 -A$0.11 Billion66.91%
2014 -A$61.94 Million25.28%
2013 -A$49.44 Million54.43%
2012 -A$32.02 Million
2010 -A$23.31 Million-30.54%
2009 -A$33.56 Million164.92%
2008 -A$12.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.29 B-124.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.46 Million-99.72% Bahamas